Drug companies overcharged NHS for hydrocortisone tablets

The CMA has imposed fines totalling over £260 million for competition law breaches in relation to the supply of hydrocortisone tablets. Prices of life-saving hydrocortisone tablets rose by over 10,000 per cent. Pharma firms bought off potential rivals to avoid them competing with their own versions of the drug and preserve their ability to increase prices.

Read the source article at Spain, Regional, UK and World News
2021-07-21 13:17:45